These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37593027)

  • 1. Retracted: Valproic Acid Inhibits Peripheral T Cell Lymphoma Cells Behaviors via Restraining PI3K/AKT Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9865432. PubMed ID: 37593027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic Acid Inhibits Peripheral T Cell Lymphoma Cells Behaviors via Restraining PI3K/AKT Pathway.
    Peng Z; Xiong J; Dong H
    Evid Based Complement Alternat Med; 2022; 2022():7350489. PubMed ID: 35966721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
    Markers D
    Dis Markers; 2023; 2023():9849123. PubMed ID: 37593569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9819824. PubMed ID: 37388518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K/AKT Pathway.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864562. PubMed ID: 37476776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Antiproliferative and apoptotic activity of glycyrrhizinic acid in MCF-7 human breast cancer cells and evaluation of its effect on cell cycle, cell migration and m-TOR/PI3K/Akt signalling pathway.
    Zhang Z; Feng Y; Li ZY; Cao XZ
    Arch Med Sci; 2023; 19(2):555. PubMed ID: 37034508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Prescription of
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9878935. PubMed ID: 37564797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9873529. PubMed ID: 36756140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted:
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9817815. PubMed ID: 37565156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Antitumor and apoptotic effects of 5-methoxypsoralen in U87MG human glioma cells and its effect on cell cycle, autophagy and PI3K/Akt signaling pathway.
    Guo H; He Y; Bu C; Peng Z
    Arch Med Sci; 2023; 19(2):556. PubMed ID: 37034538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Protective Effects of Pretreatment with Oleanolic Acid in Rats in the Acute Phase of Hepatic Ischemia-Reperfusion Injury: Role of the PI3K/Akt Pathway.
    Inflammation MO
    Mediators Inflamm; 2022; 2022():9825785. PubMed ID: 35530979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Inhibiting Autophagy Pathway of PI3K/AKT/mTOR Promotes Apoptosis in SK-N-SH Cell Model of Alzheimer's Disease.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9780432. PubMed ID: 36714419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: MicroRNA-29a-3p Regulates SH-SY5Y Cell Proliferation and Neurite Growth through Interaction with PTEN-PI3K/AKT/mTOR Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9824132. PubMed ID: 37502599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition.
    Engineering JOH
    J Healthc Eng; 2022; 2022():9864791. PubMed ID: 36619243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
    Zhang L; Liang X; Li Y
    Oncol Rep; 2021 Jan; 45(1):407. PubMed ID: 33416130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: TILRR Aggravates Sepsis-Induced Acute Lung Injury by Suppressing the PI3K/Akt Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9768306. PubMed ID: 37387989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: MicroRNA-1179 regulates proliferation and chemosensitivity of human ovarian cancer cells by targeting the PTEN-mediated PI3K/AKT signaling pathway.
    Zhihong Z; Rubin C; Liping L; Anpeng M; Hui G; Yanting W; Zhenxiu S
    Arch Med Sci; 2023; 19(2):557. PubMed ID: 37034514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
    Markers D
    Dis Markers; 2023; 2023():9791279. PubMed ID: 37476639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.